Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16115887rdf:typepubmed:Citationlld:pubmed
pubmed-article:16115887lifeskim:mentionsumls-concept:C0015576lld:lifeskim
pubmed-article:16115887lifeskim:mentionsumls-concept:C1704928lld:lifeskim
pubmed-article:16115887lifeskim:mentionsumls-concept:C0004561lld:lifeskim
pubmed-article:16115887lifeskim:mentionsumls-concept:C0162638lld:lifeskim
pubmed-article:16115887lifeskim:mentionsumls-concept:C0034805lld:lifeskim
pubmed-article:16115887lifeskim:mentionsumls-concept:C1704259lld:lifeskim
pubmed-article:16115887lifeskim:mentionsumls-concept:C1444748lld:lifeskim
pubmed-article:16115887lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:16115887lifeskim:mentionsumls-concept:C1705987lld:lifeskim
pubmed-article:16115887lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:16115887lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:16115887pubmed:issue42lld:pubmed
pubmed-article:16115887pubmed:dateCreated2005-10-17lld:pubmed
pubmed-article:16115887pubmed:abstractTextThe inhibitory Fc receptors function to regulate the antigen-driven activation and expansion of lymphocytes. In B cells, the Fc gammaRIIB1 is a potent inhibitor of B cell antigen receptor (BCR) signaling when coligated to the BCR by engagement of antigen-containing immune complexes. Inhibition is mediated by the recruitment of the inositol phosphatase, SHIP, to the Fc gammaRIIB1 phosphorylated tyrosine-based inhibitory motif (ITIM). Here we show that BCR-independent aggregation of the Fc gammaRIIB1 transduces an ITIM- and SHIP-independent proapoptotic signal that is dependent on members of the c-Abl tyrosine kinase family. These results define a novel Abl family kinase-dependent Fc gammaRIIB1 signaling pathway that functions independently of the BCR in controlling antigen-driven B cell responses.lld:pubmed
pubmed-article:16115887pubmed:languageenglld:pubmed
pubmed-article:16115887pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16115887pubmed:citationSubsetIMlld:pubmed
pubmed-article:16115887pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16115887pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16115887pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16115887pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16115887pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16115887pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16115887pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16115887pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16115887pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16115887pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16115887pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16115887pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16115887pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16115887pubmed:statusMEDLINElld:pubmed
pubmed-article:16115887pubmed:monthOctlld:pubmed
pubmed-article:16115887pubmed:issn0021-9258lld:pubmed
pubmed-article:16115887pubmed:authorpubmed-author:InabeKazunori...lld:pubmed
pubmed-article:16115887pubmed:authorpubmed-author:KurosakiTomoh...lld:pubmed
pubmed-article:16115887pubmed:authorpubmed-author:PierceSusan...lld:pubmed
pubmed-article:16115887pubmed:authorpubmed-author:BollandSilvia...lld:pubmed
pubmed-article:16115887pubmed:authorpubmed-author:TzengShiang-J...lld:pubmed
pubmed-article:16115887pubmed:issnTypePrintlld:pubmed
pubmed-article:16115887pubmed:day21lld:pubmed
pubmed-article:16115887pubmed:volume280lld:pubmed
pubmed-article:16115887pubmed:ownerNLMlld:pubmed
pubmed-article:16115887pubmed:authorsCompleteYlld:pubmed
pubmed-article:16115887pubmed:pagination35247-54lld:pubmed
pubmed-article:16115887pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:16115887pubmed:meshHeadingpubmed-meshheading:16115887...lld:pubmed
pubmed-article:16115887pubmed:meshHeadingpubmed-meshheading:16115887...lld:pubmed
pubmed-article:16115887pubmed:meshHeadingpubmed-meshheading:16115887...lld:pubmed
pubmed-article:16115887pubmed:meshHeadingpubmed-meshheading:16115887...lld:pubmed
pubmed-article:16115887pubmed:meshHeadingpubmed-meshheading:16115887...lld:pubmed
pubmed-article:16115887pubmed:meshHeadingpubmed-meshheading:16115887...lld:pubmed
pubmed-article:16115887pubmed:meshHeadingpubmed-meshheading:16115887...lld:pubmed
pubmed-article:16115887pubmed:meshHeadingpubmed-meshheading:16115887...lld:pubmed
pubmed-article:16115887pubmed:meshHeadingpubmed-meshheading:16115887...lld:pubmed
pubmed-article:16115887pubmed:meshHeadingpubmed-meshheading:16115887...lld:pubmed
pubmed-article:16115887pubmed:meshHeadingpubmed-meshheading:16115887...lld:pubmed
pubmed-article:16115887pubmed:meshHeadingpubmed-meshheading:16115887...lld:pubmed
pubmed-article:16115887pubmed:meshHeadingpubmed-meshheading:16115887...lld:pubmed
pubmed-article:16115887pubmed:meshHeadingpubmed-meshheading:16115887...lld:pubmed
pubmed-article:16115887pubmed:meshHeadingpubmed-meshheading:16115887...lld:pubmed
pubmed-article:16115887pubmed:meshHeadingpubmed-meshheading:16115887...lld:pubmed
pubmed-article:16115887pubmed:meshHeadingpubmed-meshheading:16115887...lld:pubmed
pubmed-article:16115887pubmed:meshHeadingpubmed-meshheading:16115887...lld:pubmed
pubmed-article:16115887pubmed:meshHeadingpubmed-meshheading:16115887...lld:pubmed
pubmed-article:16115887pubmed:meshHeadingpubmed-meshheading:16115887...lld:pubmed
pubmed-article:16115887pubmed:meshHeadingpubmed-meshheading:16115887...lld:pubmed
pubmed-article:16115887pubmed:meshHeadingpubmed-meshheading:16115887...lld:pubmed
pubmed-article:16115887pubmed:meshHeadingpubmed-meshheading:16115887...lld:pubmed
pubmed-article:16115887pubmed:meshHeadingpubmed-meshheading:16115887...lld:pubmed
pubmed-article:16115887pubmed:meshHeadingpubmed-meshheading:16115887...lld:pubmed
pubmed-article:16115887pubmed:meshHeadingpubmed-meshheading:16115887...lld:pubmed
pubmed-article:16115887pubmed:meshHeadingpubmed-meshheading:16115887...lld:pubmed
pubmed-article:16115887pubmed:meshHeadingpubmed-meshheading:16115887...lld:pubmed
pubmed-article:16115887pubmed:year2005lld:pubmed
pubmed-article:16115887pubmed:articleTitleThe B cell inhibitory Fc receptor triggers apoptosis by a novel c-Abl family kinase-dependent pathway.lld:pubmed
pubmed-article:16115887pubmed:affiliationLaboratory of Immunogenetics, NIAID, National Institutes of Health, Rockville, Maryland 20852, USA.lld:pubmed
pubmed-article:16115887pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16115887pubmed:publicationTypeResearch Support, N.I.H., Intramurallld:pubmed
entrez-gene:11350entrezgene:pubmedpubmed-article:16115887lld:entrezgene
entrez-gene:14130entrezgene:pubmedpubmed-article:16115887lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:16115887lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:16115887lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16115887lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16115887lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16115887lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16115887lld:pubmed